These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2856818)
1. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem. Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818 [TBL] [Abstract][Full Text] [Related]
2. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction. van Zwieten PA; van Meel JC; Timmermans PB J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of some calcium-channel blockers on human peripheral arteries and veins. Sjöberg T; Andersson KE; Norgren L; Steen S Acta Physiol Scand; 1987 Jul; 130(3):419-27. PubMed ID: 2820194 [TBL] [Abstract][Full Text] [Related]
4. [Interaction between calcium inhibitors and vascular alpha-adrenergic receptors]. van Zwieten PA; Timmermans PB Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():7-13. PubMed ID: 3004370 [TBL] [Abstract][Full Text] [Related]
5. Calcium dependency of vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors. van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; de Jonge A J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S113-20. PubMed ID: 2414571 [TBL] [Abstract][Full Text] [Related]
6. Nifedipine attenuates both alpha-1 and alpha-2 adrenoceptor-mediated pressor and vasoconstrictor responses in conscious dogs and primates. Woodman OL; Constantine JW; Vatner SF J Pharmacol Exp Ther; 1986 Dec; 239(3):648-53. PubMed ID: 3025415 [TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of newer calcium antagonists (nimodipine and PY-108-068) on vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors. Van Meel JC; Wilffert B; De Zoeten K; Timmermans PB; Van Zwieten PA Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):206-17. PubMed ID: 6299220 [TBL] [Abstract][Full Text] [Related]
8. An attempt to characterize alpha-adrenoceptors on human dorsal foot veins in situ. Barthel W Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):267-70. PubMed ID: 8101513 [TBL] [Abstract][Full Text] [Related]
9. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison of systemic vs. local effects. Pedrinelli R; Tarazi RC J Pharmacol Exp Ther; 1985 Jun; 233(3):643-9. PubMed ID: 2861275 [TBL] [Abstract][Full Text] [Related]
10. The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in man. Elliott HL; Pasanisi F; Sumner DJ; Reid JL J Hypertens Suppl; 1985 Dec; 3(3):S235-7. PubMed ID: 2856817 [TBL] [Abstract][Full Text] [Related]
11. Undifferentiated effects of calcium antagonists on pressor responses to selective alpha-1 and alpha-2 adrenoceptor agonists in anesthetized, spinal dogs. Morita T; Maniwa T; Satoh K; Taira N J Pharmacol Exp Ther; 1985 Sep; 234(3):728-34. PubMed ID: 2863372 [TBL] [Abstract][Full Text] [Related]
12. Calcium and alpha-adrenoceptors in activation of vascular smooth muscle. Vanhoutte PM; Rimele TJ J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S280-6. PubMed ID: 6184553 [TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil. Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754 [TBL] [Abstract][Full Text] [Related]
14. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins. Barrús MT; Reviriego J; Marín J J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463 [TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction. Andrawis NS; Craft N; Abernethy DR J Pharmacol Exp Ther; 1992 Jun; 261(3):879-84. PubMed ID: 1602392 [TBL] [Abstract][Full Text] [Related]
16. Antagonism by nifedipine of alpha-1 and alpha-2 adrenoceptor-mediated responses of human digital arteries. Stevens MJ; Moulds RF J Pharmacol Exp Ther; 1986 Mar; 236(3):764-9. PubMed ID: 3005555 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of alpha-1 vs. alpha-2 adrenoceptor-mediated responses in canine saphenous vein by nitroglycerin. Eskinder H; Gross GJ J Pharmacol Exp Ther; 1986 Aug; 238(2):515-21. PubMed ID: 3016240 [TBL] [Abstract][Full Text] [Related]
18. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes. Magnon M; Gallix P; Cavero I J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077 [TBL] [Abstract][Full Text] [Related]
19. Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors. Timmermans PB; Chiu AT; Thoolen MJ Can J Physiol Pharmacol; 1987 Aug; 65(8):1649-57. PubMed ID: 2891423 [TBL] [Abstract][Full Text] [Related]
20. Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes. Korstanje C; Wilffert B; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA J Cardiovasc Pharmacol; 1984; 6(6):1102-8. PubMed ID: 6084766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]